BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 11/06/1998

FDA Grants Special Termination to Dr. Dulal C. Chatterji

The FDA has lifted Dr. Dulal C. Chatterji's debarment, citing his substantial assistance in investigations and prosecutions related to FDA jurisdiction, and that this move serves the interest of justice without compromising the drug approval process.

Source: Federal Register — Food and Drug AdministrationOpen original release →